The complete history of GLP-1 drugs — from 1902 incretin research to exenatide (2005), Victoza (2010), Ozempic (2017), Rybelsus (2019), Wegovy (2021), Mounjaro (2022), Zepbound (2023), and pipeline candidates retatrutide and orforglipron — with where PlexusDx Semaglutide, Tirzepatide, Microdose, and GLP-Squared protocols fit in 2026.

The honest 2026 trade-off on GLP-1 medications: substantial weight loss and cardiometabolic benefits balanced against GI side effects, cost, lean-mass loss risk, and long-term maintenance. Compares branded vs compounded options and where PlexusDx Weight Management Protocols fit at $129–$509/mo across six protocols.

Embody GLP-1 review vs PlexusDx: Embody locks semaglutide refills at $299/month (~$3,438/year) after the intro tier; PlexusDx Microdose GLP-1 Protocol is $129/mo flat ($1,548/year) and Semaglutide Injection is $179–$229/mo. Both use compounded medications; PlexusDx adds the Precision Peptide Genetic Test for genetics-informed dosing.

Eden vs GALA GLP-1 vs PlexusDx (April 2026): verified pricing, refund and cancellation rules, medication menus, and where a genetic baseline changes the dose conversation. Eden is the broad menu; GALA is the lowest annual commitment price; PlexusDx pairs six compounded protocols with the Precision Peptide Genetic Test.

An honest read on the cons of GLP-1 therapy — GI side effects, the boxed warning, cost, weight regain on cessation, and body composition — plus where PlexusDx Weight Management Protocols ($129–$325/mo, all 50 states, no membership) fit when insurance friction is itself one of the cons.

The cheapest GLP-1 without insurance online in 2026, ranked by 12-month cash-pay total. PlexusDx Microdose GLP-1 Protocol at $129/mo flat ($1,548/year) lands below Wegovy tablets, Tuyo Health, Breeze Meds, MEDVi, and Zepbound vials — with the optional Precision Peptide Genetic Test as a $99 add-on for genetics-anchored dosing.

Compare the 2026 best Foundayo (orforglipron) providers — Ro, Found, Form Health, Sesame Care, Weight Watchers Med+, and LillyDirect — and see where the PlexusDx Weight Management Protocols fit as a cash-pay, genetics-informed alternative when insurance excludes weight-loss drugs.

Strut Health review: oral semaglutide lozenges $99-$149/mo, injectable $149-$289/mo, FDA warning letter Feb 2026, D+ BBB rating, cancellation friction. Compared to PlexusDx Microdose GLP-1 ($129/mo), Semaglutide Injection ($179-$229/mo), and Tirzepatide Injection ($229-$309/mo) with the optional Precision Peptide Genetic Test for dose personalization.

Piper (rebranding to Polly April 29, 2026) vs Gala GLP-1 vs PlexusDx: verified April 2026 pricing, pharmacy transparency, cancellation rules, and where a genetic baseline changes the dosing conversation.

Mounjaro cost without insurance runs $987–$1,112/month at U.S. pharmacies in April 2026. The $25 savings card requires commercial insurance, and Lilly Direct's $499 self-pay price is for Zepbound, not Mounjaro. PlexusDx Tirzepatide Injection at $229–$309/month is a compounded cash-pay alternative using the same active ingredient.

GLP-3 retatrutide explained: triple-agonist mechanism, Phase 3 TRIUMPH data, dysesthesia signal, FDA timeline, and how PlexusDx’s currently-available compounded semaglutide and tirzepatide protocols compare to the pipeline asset.

CareCredit can pay for GLP-1 at Walgreens, Walmart, Sam's Club, and a few telehealth providers — but promotional 0% financing doesn't apply at retail pharmacy counters, and the standard APR is 32.99%. We run the annual cost math against PlexusDx flat cash-pay protocols ($129–$309/mo) and explain why HSA/FSA almost always beats financing.

Hers accepts HSA/FSA via reimbursement (pay with regular card, submit receipt). PlexusDx accepts HSA/FSA card payment at checkout where your plan permits, with no membership fee — protocols from $129/mo, all 50 states.

Mounjaro is FDA-approved tirzepatide for type 2 diabetes; Zepbound is the weight-loss-indicated brand. Compare branded Mounjaro online vs cash-pay compounded tirzepatide and where PlexusDx Tirzepatide Injection ($229–$309/mo) fits.

Zepbound prior authorization explained: BMI and comorbidity criteria, the OSA pathway, the CVS Caremark formulary change, ERISA timelines, and how to appeal a denial. Plus where the PlexusDx Tirzepatide Injection Protocol ($229–$309/mo) fits as a cash-pay bridge while a PA is pending or after a denial.

Eight month-to-month GLP-1 providers compared against PlexusDx Weight Management Protocols on real annual cost, hidden membership fees, intro-price cliffs, and genetic baseline. PlexusDx Microdose at $129/mo flat, Semaglutide Injection $179–$229, Tirzepatide Injection $229–$309, GLP-Squared $179–$325 — all cash-pay, no membership.

MEDVi shipping time is a published 5–7 business days — physician review, compounding-pharmacy processing, and carrier transit. See how that timeline compares to PlexusDx Weight Management Protocols, which ship to all 50 states with shipping included in the all-inclusive monthly price (from $129/mo) and no membership fee.

Henry charges $297/month flat for compounded semaglutide or tirzepatide with consultation and shipping included — comprehensive but mid-to-upper tier. We compare Henry's annualized cost ($3,564/year) against PlexusDx Weight Management Protocols ($1,548–$3,900/year), explain the compounded vs FDA-approved branded medication question, and walk through dose flexibility and genetic baseline differences so you can pick the right cash-pay GLP-1 route.

Emerging research suggests GLP-1 receptor agonists like semaglutide and tirzepatide may reduce cravings for alcohol and other substances by modulating dopamine signaling in the brain’s reward circuitry — the same “food noise” mechanism that drives weight-loss outcomes. No GLP-1 is FDA-approved for any addiction indication. This guide explains what the human evidence actually shows, substance by substance, and how PlexusDx Weight Management Protocols are positioned for chronic weight management only.

Eden publishes flat compounded GLP-1 pricing — $209–$229/mo for semaglutide and $329/mo for tirzepatide. We map those numbers against the full PlexusDx Weight Management Protocol lineup ($129–$509/mo) and walk the annualized cost math at every dose tier.

DudeMeds advertises compounded semaglutide and tirzepatide from $149+/month with no membership fee, but dose-escalation pricing is not consistently published and review depth is still thin. This review compares DudeMeds against PlexusDx Weight Management Protocols (Microdose GLP-1 at $129/mo flat, Semaglutide Injection $179–$229/mo, Tirzepatide Injection $229–$309/mo) and the optional Precision Peptide Genetic Test for genetic-informed titration.

Compounding pharmacy shut down or lost 503A status for GLP-1s? A 2026 patient continuity guide: first 24-hour checklist, the four scenarios, what a warning letter actually means, three pharmacy-verification lookups, and how PlexusDx Semaglutide Injection ($179-$229/mo), Tirzepatide Injection ($229-$309/mo), Microdose GLP-1 Protocol ($129/mo), GLP-Squared ($179-$325/mo), and the Precision Peptide Genetic Test ($99 add-on) handle transfer patients.

The cheapest GLP-1 with insurance is roughly $25/month on Wegovy, Zepbound, Ozempic, Mounjaro, or Foundayo when your commercial plan covers the drug and you stack the manufacturer savings card. Only 43% of commercially insured users hit that scenario. When insurance won't cover a weight-loss GLP-1, PlexusDx cash-pay protocols start at $129/mo flat - cheaper than every branded self-pay route.

TrimRx vs Henry Meds vs PlexusDx compared on real annual cost, pricing transparency, reviews, BBB, FDA status, and genetic-guided dosing. TrimRx $199/mo standard async; Henry Meds $297/mo standard with video visit; PlexusDx from $129/mo with optional Precision Peptide Genetic Test ($99 add-on).

Sprout Health offers compounded semaglutide at $249/mo and compounded tirzepatide at $299/mo across 44 states with documented slow customer service. Compare Sprout's pricing, state coverage, FDA-approval status, and clinical model with PlexusDx Weight Management Protocols ($129-$309/mo, all 50 states, optional Precision Peptide Genetic Test).

The seven non-negotiable questions to ask before any GLP-1 telehealth consult, with green/yellow/red answer guides — pharmacy identity (503A vs 503B), compounded vs FDA-approved, total cost across month one through highest maintenance dose, escalation path, and the genetic-baseline question most cash-pay platforms skip.

Step-by-step guide to getting a GLP-1 prescribed online in 2026: eligibility self-screen, the three pathways (insurance, branded cash-pay, compounded cash-pay), pharmacy verification, and how PlexusDx Weight Management Protocols handle the telehealth pathway in all 50 states with no membership fee.

Your GLP-1 protein target is 1.0–1.5 g/kg/day during active weight loss — meaningfully above the 0.8 g/kg RDA. This guide gives you the math, per-meal distribution, nausea-day food list, and where the PlexusDx Semaglutide Injection, Tirzepatide Injection, and Microdose GLP-1 protocols sit relative to those targets.

Hit a GLP-1 plateau on semaglutide or tirzepatide? Walk the 7-step diagnostic, the dose-escalation playbook, the semaglutide-to-tirzepatide switch decision, GLP-Squared dual-compound therapy for resistant cases, and the GLP1R/GIPR genetic angle that explains why population-average titration fails some patients.

FDA labels list hair loss in 3% of Wegovy and 4–5% of Zepbound users, but the real trigger is rapid weight loss producing telogen effluvium — a reversible 6–12 month shedding pattern. This guide covers the FDA evidence, the timeline you can plan around, why women report it more often, the genetic variants behind GLP-1 response, and how a slower-titration PlexusDx protocol plus the Precision Peptide Genetic Test reduces risk before week one.